Fact Sheet: Ncyte® Microglia
Get information on Ncardia’s Ncyte® Microglia, human iPSC-derived microglia that can help advance CNS and neurodegenerative therapy research
DOWNLOAD NOW
ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.